![]() Inotrem Inotrem is a biotech company specializing in the discovery and development of novel treatments in the field of inflammatory pathologies with a focus on critical care. | ![]() Virogenics Virogenics is a company that specializes in the research and development of gene therapies and stem cell technology. | ![]() Vedanta Biosciences Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. | ![]() Trefoil Therapeutics Trefoil Therapeutics is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop regenerative pharmacologic treatments for corneal diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2003 | Founding Date 2010 | Founding Date 2015 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Paris, FR HQ Paris, FR Vandœuvre Lès Nancy, FR | Locations San Diego, US HQ | Locations Cambridge, US HQ | Locations Waltham, US HQ | Locations San Diego, US HQ |
Employees | Employees N/A | Employees 4 | Employees 1381% increase | Employees 76 | Employees 138% increase |
Funding | |||||
Latest funding round | Latest funding round $ 5.5m (about 6 years ago) | Latest funding round $ 6m (over 13 years ago) | Latest funding round $ 68m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 28m (almost 7 years ago) |
Total funding raised | Total funding raised $ 71.6m | Total funding raised $ 6m | Total funding raised $ 185.5m | Total funding raised $ 131.5m | Total funding raised $ 33.2m |

Virogenics is a company that specializes in the research and development of gene therapies and stem cell technology.
View company
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
View company
Morphic Therapeutic operates as a biotechnology company.
View company
Trefoil Therapeutics is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop regenerative pharmacologic treatments for corneal diseases.
View company